ALLMedicine™ Dysfibrinogenemia Center
Research & Reviews 161 results
https://doi.org/10.1097/MBC.0000000000001000
Blood Coagulation & Fibrinolysis : an International Journ... Marchi R, Neerman-Arbez M et. al.
Jan 14th, 2021 - Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrino...
https://doi.org/10.1111/ijlh.13358
International Journal of Laboratory Hematology REFERENCES; Arai S, Kamijo T et. al.
Oct 8th, 2020 - Congenital fibrinogen disorders (CFDs) are classified as afibrinogenemia or hypofibrinogenemia (Hypo), dysfibrinogenemia (Dys), or hypodysfibrinogenemia (Hypodys), according to functional and antigenic fibrinogen concentrations. However, in routin...
https://doi.org/10.1016/j.thromres.2020.08.031
Thrombosis Research; Yoda M, Kaido T et. al.
Sep 1st, 2020 - Congenital fibrinogen disorders result from genetic mutations in FGA, FGB, or FGG resulting in quantitative fibrinogen deficiencies (afibrinogenemia or hypofibrinogenemia) or qualitative fibrinogen deficiencies (dysfibrinogenemia). Hypodysfibrinog...
https://doi.org/10.1097/MBC.0000000000000951
Blood Coagulation & Fibrinolysis : an International Journ... Fager Ferrari M, Leinoe E et. al.
Aug 27th, 2020 - : Fibrinogen is essential for normal hemostasis. Congenital fibrinogen disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia), caused by pathogenic variants in the genes FGA, FGB and FGG, have the potential of...
https://doi.org/10.1097/MBC.0000000000000948
Blood Coagulation & Fibrinolysis : an International Journ... Luo S, Xu Q et. al.
Aug 24th, 2020 - : The aim of this study was to elucidate the molecular defects in a Chinese family with dysfibrinogenemia. The fibrinogen activity was measured by the one-stage clotting method. The fibrinogen antigen was measured with immunoturbidimetry. The fibr...
Drugs 1 results see all →
Clinicaltrials.gov 163 results
https://doi.org/10.1097/MBC.0000000000001000
Blood Coagulation & Fibrinolysis : an International Journ... Marchi R, Neerman-Arbez M et. al.
Jan 14th, 2021 - Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrino...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=007a93f4-d84b-1fa9-51ed-32f6140bf423
Dec 21st, 2020 - FIBRYGA is a human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in adults and children with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. FIBRYGA is not indicated for dysfibrin...
https://doi.org/10.1111/ijlh.13358
International Journal of Laboratory Hematology REFERENCES; Arai S, Kamijo T et. al.
Oct 8th, 2020 - Congenital fibrinogen disorders (CFDs) are classified as afibrinogenemia or hypofibrinogenemia (Hypo), dysfibrinogenemia (Dys), or hypodysfibrinogenemia (Hypodys), according to functional and antigenic fibrinogen concentrations. However, in routin...
https://doi.org/10.1016/j.thromres.2020.08.031
Thrombosis Research; Yoda M, Kaido T et. al.
Sep 1st, 2020 - Congenital fibrinogen disorders result from genetic mutations in FGA, FGB, or FGG resulting in quantitative fibrinogen deficiencies (afibrinogenemia or hypofibrinogenemia) or qualitative fibrinogen deficiencies (dysfibrinogenemia). Hypodysfibrinog...
https://doi.org/10.1097/MBC.0000000000000951
Blood Coagulation & Fibrinolysis : an International Journ... Fager Ferrari M, Leinoe E et. al.
Aug 27th, 2020 - : Fibrinogen is essential for normal hemostasis. Congenital fibrinogen disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia), caused by pathogenic variants in the genes FGA, FGB and FGG, have the potential of...
